Manansad, Stephen Jay C.

HRN: 11-96-70  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/19/2022
CEFUROXIME 1.5GM (VIAL)
11/19/2022
11/26/2022
IV
400mg
Q8
Febrile Neutropenia
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Febrile Neutropenia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: